Häftad, Engelska, 2020
Drug Discovery Targeting Drug-Resistant Bacteria
Av Prashant Kesharwani, Sidharth Chopra, Arunava Dasgupta
2689 kr
Beställningsvara. Skickas inom 11-20 vardagar. Fri frakt för medlemmar vid köp för minst 249 kr.
Beskrivning
Drug Discovery Targeting Drug-Resistant Bacteria explores the status and possible future of developments in fighting drug-resistant bacteria. The book covers the majority of microbial diseases and the drugs targeting them. In addition, it discusses the potential targeting strategies and innovative approaches to address drug resistance. It brings together academic and industrial experts working on discovering and developing drugs targeting drug-resistant (DR) bacterial pathogens. New drugs active against drug-resistant pathogens are discussed, along with new strategies being used to discover molecules acting via new modes of action. In addition, alternative therapies such as peptides and phages are included.
Pharmaceutical scientists, microbiologists, medical professionals, pathologists, researchers in the field of drug discovery, infectious diseases and microbial drug discovery both in academia and in industrial settings will find this book helpful.
- Written by scientists with extensive industrial experience in drug discovery
- Provides a balanced view of the field, including its challenges and future directions
- Includes a special chapter on the identification and development of drugs against pathogens which exhibit the potential to be used as weapons of war
Produktinformation
- Utgivningsdatum: 2020-05-15
- Mått: 191 x 235 x undefined mm
- Vikt: 880 g
- Format: Häftad
- Språk: Engelska
- Antal sidor: 432
- Förlag: Elsevier Science
- ISBN: 9780128184806
Utforska kategorier
Mer information
Dr. Prashant Kesharwani, PhD, is an Assistant Professor of Pharmaceutics at Department of Pharmaceutical Sciences, Dr.Harisingh Gour Vishwavidyalaya University, Sagar, Madhya Pradesh, India. He has more than 12 years of teaching, research,and industrial experience across various countries. An overarching goal of his current research is the development ofnanoengineered drug delivery systems for various diseases. He has more than 400 international publications in well-reputedjournals and more than 30 international books (Elsevier). His work has garnered 40,000 + citations, with an h-index of above100, making him one of the youngest Indian researchers to achieve an h-index of 100 at the age of 41. He is a recipientof many research grants from various funding bodies. He is also the recipient of several internationally acclaimed awards,such as “USERN Laureate award and “SERB-Ramanujan Fellowship Award. He has presented many invited talks and oralpresentations at prestigious scientific peer-conferences, received international acclaims and awards for research contribution,supervised students/junior researchers, and actively participated in outreach and scientific dissemination for the service ofthe wider community. Dr. Sidharth Chopra is a Senior Scientist, at Division of Microbiology, CSIR-Central Drug Research Institute, Lucknow, India. He has ~35 international publications in well reputed journals. One of his article is published in Bioresource technology 77 (3), 215-227 with 999 citations and he has extensively worked on discovery and development of NCE against ESKAPE, mycobacterial infections as well as biothreat pathogens. Dr. Arunava Dasgupta a Senior Scientist, at Division of Microbiology, CSIR-Central Drug Research Institute, Lucknow, India. He has ~20 international publications in well reputed journals. He has extensively worked on discovery and development of NCE against mycobacterial infections as well as understanding hostpathogen interaction.
Recensioner i media
"This book provides quality information and is a good educational tool." --Doody
Butikslager
Ej i lager i butik.
Betyg & recensioner
0 recensioner
Inga recensioner tillgängliga.